Clinical Trials Logo

Cocaine Use Disorder clinical trials

View clinical trials related to Cocaine Use Disorder.

Filter by:

NCT ID: NCT04843046 Recruiting - Clinical trials for Cocaine Use Disorder

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Start date: August 23, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see how well pioglitazone, when used with cognitive behavioral therapy, works at helping people who have recently stopped using cocaine to continue to not use cocaine.

NCT ID: NCT04721418 Recruiting - Clinical trials for Cocaine Use Disorder

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study

Start date: July 20, 2021
Phase:
Study type: Observational

The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.

NCT ID: NCT04296006 Recruiting - Clinical trials for Cocaine Use Disorder

Neurobehavioral Mechanisms of Cocaine Choice

Start date: January 15, 2021
Phase: Early Phase 1
Study type: Interventional

The objective of this protocol is to use a drug-vs-money choice task, reinforcement learning modeling and fMRI to determine the neurobehavioral and neurobiological decision-making "profile" associated with the decision to take cocaine and the reduced cocaine choice that occurs during behavioral and pharmacological interventions.

NCT ID: NCT03833583 Recruiting - Cocaine Dependence Clinical Trials

tDCS to Reduce Craving in Cocaine Addiction

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of this approach to 1) reduce an individual's level of drug craving and 2) provide evidence to support the use of this device by the patient for future unsupervised stimulation in a non-clinical setting. Research Questions: - Can tDCS be used successfully to train cocaine addicted individuals for self-administration purposes? - Can active tDCS be used to decrease drug craving in individuals with cocaine use disorders? - Does active tDCS outperform sham tDCS in reducing drug craving?

NCT ID: NCT03733821 Recruiting - Sleep Disturbance Clinical Trials

Subjective Sleep Quality in CUD TMS-Treated

Start date: January 2015
Phase:
Study type: Observational

Sleep disruptions are prevalent complaints in cocaine use disorder (CUD) subjects, either during consumption or withdrawal. Repetitive transcranial magnetic stimulation (rTMS) seem to be a promissing strategy in the treatment of chronic cocaine users. The aim of this study will be to assess the variation on self-perceived sleep quality and drug use variables in individuals with CUD undergoing a rTMS protocol over the left dorsolateral prefrontal cortex (DLPFC).

NCT ID: NCT03656653 Recruiting - Clinical trials for Cocaine Use Disorder

Imagery-based Coping for Cocaine Use Disorder

CIIC
Start date: October 30, 2018
Phase: N/A
Study type: Interventional

A pragmatic, 4-week, 4-group, between-subjects, factorial randomised controlled trial conducted at a specialist NHS outpatient addictions clinic and hospital clinical research facility to determine if mental imagery (of past and future positive [recovery oriented] and negative [cocaine aversive] events) can help reduce cue-induced cocaine craving and cocaine use.

NCT ID: NCT03344419 Recruiting - Clinical trials for Cocaine Use Disorder

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Start date: October 1, 2017
Phase: Phase 3
Study type: Interventional

Changes in the communication of glutamate from one brain structure to another are important in the development of therapy for cocaine use disorders. Our preliminary investigations suggest that drugs that affect glutamate exchange may be effective at promoting and maintaining individuals' abstinence from cocaine. The purpose of this randomized, double-blind, controlled trial is to test various glutamate modulators in conjunction with motivational enhancement therapy (MET) and mindfulness based relapse prevention (MBRP) for cocaine use disorders.

NCT ID: NCT02927236 Recruiting - Cocaine Dependence Clinical Trials

Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use

Start date: February 13, 2017
Phase: Phase 4
Study type: Interventional

Background: More effective treatments for people with cocaine use disorder are needed. Researchers want to understand the parts of the brain involved in the disorder. Transcranial magnetic stimulation (TMS) stimulates parts of the brain. A form of TMS called intermittent theta-burst stimulation (iTBS) may help reduce cocaine use. Researchers want to learn how the brain might change with treatment. Objectives: To test if iTBS can reduce cocaine use. Also, to learn how cocaine changes the heart and the brain. Eligibility: Healthy, right-handed adults ages 18-60 who do or do not have cocaine use disorder. Design: Participants will be screened with: - Questionnaires - Medical history - Physical exam - Blood and urine tests - Alcohol breath tests In the pilot study, 10 participants with cocaine use disorder will have 10 treatment days over 2 weeks. Half will be inpatient and half will be outpatient. They will have 2 follow-up visits. Treatment includes: - iTBS: A coil is placed on the head. A brief electrical current passes through the coil. They view cocaine-related images during each session. Sessions are videotaped. - Repeat of screening tests - In the main study, participants will be randomly assigned to have either real or fake iTBS. - Participants with cocaine use disorder will join an incentive program to quit. - Participants will have 39 visits over 6 months. These include: - Repeat of screening tests - MRIs at 5 visits: Participants lie on a table that slides into a cylinder that takes pictures of the brain. They respond to images while in the scanner. - iTBS at 10 visits (5 days a week for 2 weeks) Participants will be contacted throughout the study to discuss iTBS treatment and drug use.